Company profile for Philip Morris International

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Since 2008, here at Philip Morris International, we’ve invested more than USD 8.1 billion into the science and research of developing smoke-free products, and we employ more than 400 world-class scientists, engineers, and technicians to help us. Philip Morris International (PMI) is a leading international tobacco company engaged in the manufacture and sale of cigarettes, smoke-free products and associated electronic devices...
Since 2008, here at Philip Morris International, we’ve invested more than USD 8.1 billion into the science and research of developing smoke-free products, and we employ more than 400 world-class scientists, engineers, and technicians to help us. Philip Morris International (PMI) is a leading international tobacco company engaged in the manufacture and sale of cigarettes, smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in markets outside the U.S. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
120 Park Avenue New York, NY 10017
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251008608945/en/Philip-Morris-International-Urges-U.S.-Food-and-Drug-Administration-Advisory-Committee-to-Recommend-Continued-Marketing-of-IQOS-as-Modified-Risk-Product

BUSINESSWIRE
08 Oct 2025

https://www.businesswire.com/news/home/20250502143425/en/PMI-U.S.-Reveals-Ft.-Lauderdale-as-Next-IQOS-Launch-City-to-Provide-Residents-21-Who-Smoke-a-Better-Alternative-to-Leave-Cigarettes-Behind

BUSINESSWIRE
02 May 2025

https://www.businesswire.com/news/home/20250430861009/en/PMI-U.S.-IQOS-System-Now-Commercially-Available-to-Austinites-21-Looking-for-a-Better-Alternative-to-Cigarettes

BUSINESSWIRE
30 Apr 2025

https://www.globenewswire.com/news-release/2025/04/25/3068314/0/en/Mangoceuticals-Announces-Strategic-Entry-into-High-Growth-Pouch-Industry-Through-Acquisition-of-Smokeless-Technology-IP-and-Appointment-of-Tim-Corkum-Ex-Philip-Morris-Executive-to-.html

GLOBENEWSWIRE
25 Apr 2025

https://www.prnewswire.com/news-releases/fda-authorizes-marketing-of-20-zyn-nicotine-pouch-products-after-extensive-scientific-review-302353417.html

PR NEWSWIRE
16 Jan 2025

https://www.businesswire.com/news/home/20240917390554/en

BUSINESSWIRE
17 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty